Cytotoxic t Cells
Cytotoxic T cells, also known as killer T cells, are the key players in the immune response against cancerous cells. These specialized cells recognize and eliminate cancerous cells by inducing programmed cell death, a process called apoptosis. Cytotoxic T cells use a unique mechanism to eliminate cancer cells. They recognize the cancerous cells by detecting specific molecular markers on the surface of these cells. Once they identify a cancerous cell, they release cytotoxic granules containing specialized proteins, such as perforin and granzyme, which damage the cancerous cell's DNA and induce apoptosis. Cancerous cells can evade the cytotoxic T cell response by developing defense mechanisms, such as down-regulating the expression of molecular markers that are recognized by these cells. To overcome this challenge, cancer researchers are developing new therapeutic strategies that activate and enhance the activity of cytotoxic T cells. One promising approach is the use of cancer vaccines that aim to induce a specific immune response against cancerous cells. Another promising approach is the use of immune checkpoint inhibitors, which block the molecules that inhibit the action of cytotoxic T cells. In summary, cytotoxic T cells play a critical role in the body's natural defense against cancerous cells. These cells recognize and eliminate cancerous cells through a unique mechanism, inducing programmed cell death. Researchers are exploring new ways to activate and enhance the activity of cytotoxic T cells against cancerous cells, with the aim of developing more effective cancer treatments.
← Hematology Research and Oncology Research